We are live on ! Find out more
AAP

Ardsley Advisory Partners Portfolio holdings

AUM $960M
1-Year Est. Return 207.76%
This Fund
S&P 500
This Quarter Est. Return
+2.57%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$742M
AUM Growth
+$77.4M
Cap. Flow
+$66.4M
Cap. Flow %
8.94%
Top 10 Hldgs %
43.14%
Holding
204
New
54
Increased
39
Reduced
33
Closed
53

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$20.7M
2
GLNG icon
Golar LNG
GLNG
+$14.2M
3
BABA icon
Alibaba
BABA
+$13.9M
4
PANW icon
Palo Alto Networks
PANW
+$13.4M
5
MU icon
Micron Technology
MU
+$12.4M

Sector Composition

Rank Sector Weight
1 Healthcare 16.21%
2 Technology 15.93%
3 Energy 8.03%
4 Industrials 7.92%
5 Utilities 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDK
126
CALL
DELISTED
CDK Global, Inc.
CDK
$313K 0.04%
+5,000
New +$317K
TMX
127
DELISTED
Terminix Global Holdings, Inc.
TMX
$310K 0.04%
+7,465
New +$299K
EIGR
128
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$300K 0.04%
833
TSN icon
129
Tyson Foods
TSN
$21.5B
$298K 0.04%
+5,000
New +$313K
ZEN
130
DELISTED
ZENDESK INC
ZEN
$284K 0.04%
+4,000
New +$255K
PCTY icon
131
Paylocity
PCTY
$7.43B
$281K 0.04%
3,500
-11,000
-76% -$779K
HROW icon
132
Harrow
HROW
$1.47B
$278K 0.04%
100,000
CHRS icon
133
Coherus Oncology
CHRS
$222M
$248K 0.03%
15,000
RCKT icon
134
Rocket Pharmaceuticals
RCKT
$343M
$246K 0.03%
10,000
EA icon
135
Electronic Arts
EA
$52.4B
$241K 0.03%
2,000
-3,000
-60% -$387K
OPCH icon
136
Option Care Health
OPCH
$3.53B
$233K 0.03%
18,750
LITS
137
Lite Strategy Inc
LITS
$33M
$216K 0.03%
2,500
NGD
138
CALL
DELISTED
New Gold Inc
NGD
$198K 0.03%
250,000
SPWR
139
DELISTED
SunPower Corporation Common Stock
SPWR
$183K 0.02%
+38,175
New +$181K
KPTI icon
140
Karyopharm Therapeutics
KPTI
$161M
$179K 0.02%
700
-667
-49% -$184K
HTGM
141
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$177K 0.02%
+194
New +$128K
VKTX icon
142
Viking Therapeutics
VKTX
$3.93B
$174K 0.02%
10,000
-25,000
-71% -$298K
MNDT
143
DELISTED
Mandiant, Inc. Common Stock
MNDT
$170K 0.02%
+10,000
New +$160K
CZR
144
DELISTED
Caesars Entertainment Corporation
CZR
$154K 0.02%
+15,000
New +$158K
NUGT icon
145
Direxion Daily Gold Miners Index Bull 2X ETF
NUGT
$855M
$130K 0.02%
+2,000
New +$174K
NEPT
146
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$97K 0.01%
+18
New +$86.8K
RNTX
147
Rein Therapeutics
RNTX
$66.9M
$83K 0.01%
+1,500
New +$101K
ATNM icon
148
Actinium Pharmaceuticals
ATNM
$27.2M
$59K 0.01%
+2,667
New +$54.3K
ENZ
149
DELISTED
Enzo Biochem, Inc.
ENZ
$41K 0.01%
+10,000
New +$45.4K
SEEL
150
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$31K ﹤0.01%
+1
New +$36.8K

Similar funds

Ardsley Advisory Partners's Q3 2018 Portfolio in Review

As of Q3 2018, Ardsley Advisory Partners held 204 positions worth $742M, up 12% from $665M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Ardsley Advisory Partners deployed $66.4M of net new capital in Q3 2018, opening 54 new positions and adding to 39 existing holdings. Its largest new stake was Knight Transportation: 500,000 shares worth $17.2M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 22% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Golar LNG, an estimated $14.2M trimmed.

  • Ardsley Advisory Partners's largest Q3 2018 buy was Knight Transportation: 500,000 shares worth $17.2M.
  • Ardsley Advisory Partners added most to Amyris Inc. in Q3 2018, an estimated $16.4M increase.
  • Ardsley Advisory Partners's biggest Q3 2018 reduction was Golar LNG, cutting an estimated $14.2M.
  • Ardsley Advisory Partners fully exited Baidu in Q3 2018, selling an estimated $20.7M.
  • Ardsley Advisory Partners's ten largest holdings make up 43% of its $742M portfolio in Q3 2018.
  • Ardsley Advisory Partners opened 54 new positions and closed 53 in Q3 2018.
  • Ardsley Advisory Partners's portfolio value rose 12% quarter-over-quarter to $742M.

Based on Ardsley Advisory Partners's 13F filing for Q3 2018, filed 14 Nov 2018.